NFE2L2 and neoplasm: Increased ROS conversely promote the expression of KRAS and Nrf2 under oxidative stress, and the ectopic expression of KRASG12D or KRASG12V stimulates Nrf2[112], supporting KRASG12D-driven tumor development [90].